Nexeon MedSystems Belgium

Nexeon MedSystems Belgium is a bioelectronics company that develops and manufactures active implantable medical devices and the software platforms that support the IoT tech connectivity of these devices.

NMB is affiliated to an American company, Nexeon MedSystems Inc., led by Chairman and CEO Will Rosellini.

NMB is preparing for a 2017 European commercial launch for it's leading product the Synapse, a deep brain neurostimulation system used for the treatment of symptoms associated with Parkinson's disease.

The Company also has a very active R&D division that is committed to expanding the application of its superior technology to other disease indications. 

Principaux outils d’accompagnements actionnés par WBC

  1. Expertise financière
  2. Diffusion de l'actualité des sociétés accompagnées sur les différents réseaux de WBC (Site Web, LinkedIn, Scoop'It, Twitter, Google +,...)
  3. Ressources tangibles (matériels de laboratoire, machines, prototype, surface adaptée, etc.)

t